Enumeration of NKG2C+natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia
- 19 March 2015
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 87 (9) , 1601-1607
Abstract
The role of Natural killer (NK) cells in the control of cytomegalovirus (CMV) infection in allogeneic stem cell transplant recipients has not been precisely characterized. The current study is aimed at investigating the potential role of NK cells expressing the activating receptor NKG2C in affording protection against the development of CMV DNAemia in patients exhibiting detectable CMV‐specific CD8+ T‐cell responses early following transplantation. A total of 61 nonconsecutive patients were included in the study. Peripheral levels of CD56brightCD16−/low and CD56dimCD16+ NKG2C+ NK cells and CMV pp65/IE‐1‐specific IFN‐γ‐producing CD8+ T‐cells were enumerated by flow cytometry at days +30 and +60 after transplant. Neither the absolute number of NKG2C+ NK cells, nor that of CD56brightCD16−/low and CD56dimCD16+ NKG2C+ NK‐cell subsets at day 30 differed significantly between patients with or without subsequent CMV DNAemia. No significant correlation was found between levels of both NKG2C+ NK‐cell populations and the peak CMV DNA load within subsequent episodes of CMV DNAemia. The data indicate that enumeration of NKG2C+ NK cells early after transplant is unlikely to be helpful in identifying those patients at highest risk of developing CMV DNAemia. Moreover, the data do not support a direct implication of NKG2C+ NK cells in preventing the development of CMV DNAemia. J. Med. Virol. 87:1601–1607, 2015.Keywords
Funding Information
- FIS (Fondo de Investigaciones Sanitarias, Ministerio de Sanidad y Consumo, Spain) (09/1117, 12/1992)
This publication has 15 references indexed in Scilit:
- Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationHaematologica, 2014
- Impact of HCMV Infection on NK Cell Development and Function after HSCTFrontiers in Immunology, 2013
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent functionBlood, 2012
- Functional profile of cytomegalovirus (CMV)‐specific CD8+ T cells and kinetics of NKG2C+ NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipientsJournal of Medical Virology, 2011
- Expansion of a unique CD57+NKG2Chinatural killer cell subset during acute human cytomegalovirus infectionProceedings of the National Academy of Sciences, 2011
- Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quantitation of Plasma Cytomegalovirus DNAemia in Allogeneic Stem Cell Transplant RecipientsJournal of Clinical Microbiology, 2011
- Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)–Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2009
- Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant RecipientsJournal of Clinical Microbiology, 2008
- Human NK cells can control CMV infection in the absence of T cellsBlood, 2008
- Imprint of human cytomegalovirus infection on the NK cell receptor repertoireBlood, 2004